Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. May 27, 2022; 14(5): 452-469
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.452
Figure 3
Figure 3 Overall survival and disease-free survival in neoadjuvant chemotherapy-laparoscopic total gastrectomy and neoadjuvant chemotherapy-open total gastrectomy groups. A: Overall survival between the two groups; B: Disease-free survival between the two groups. NACT: Neoadjuvant chemotherapy; LTG: Laparoscopic total gastrectomy; OTG: Open total gastrectomy.